The Dark Side Of The Electric Vehicle Boom

From The Gold Letter | Ad

There's not enough of this valuable resource to meet demand. But this company might change that...

Get The Inside Scoop Now

AQST Insider Trading (Aquestive Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $447,503.00

Aquestive Therapeutics Insider Trading History Chart

Aquestive Therapeutics Share Price & Price History

^$3.24

▼ -0.21 (-6.09%)

As of 07/30/2021 04:49 PM ET

Days: 30 | 90 | 365

This stock could soar as cannabis beverage sales hit $2.5 billion

From All Marijuana Stocks | Ad

A popular Seattle cannabis manufacturer is now partnering with other companies to produce a new line of cannabis-infused beverages. It’s perfect timing. A new report reveals cannabis beverage sales will reach $2.8 billion by 2025, expanding at an annual compounded rate of 17.8%. A huge opportunity!

Find out why this could be the #1 penny stock

Aquestive Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/10/2021	Alexander Mark Schobel	Insider	Sell	23,460	$6.75	$158,355.00	860,460
2/8/2021	Alexander Mark Schobel	Insider	Sell	40,792	$6.50	$265,148.00	860,460
8/18/2020	John T Maxwell	CFO	Sell	3,000	$8.00	$24,000.00	150,614
6/4/2020	Keith J Kendall	CEO	Sell	50,000	$5.11	$255,500.00	638,964
4/29/2020	Alexander Mark Schobel	Insider	Sell	40,000	$4.50	$180,000.00	1,022,113
4/27/2020	Alexander Mark Schobel	Insider	Sell	40,000	$4.00	$160,000.00	982,113
4/14/2020	Alexander Mark Schobel	Insider	Sell	40,000	$3.70	$148,000.00	982,113
3/16/2020	Lori J Braender	SVP	Buy	14,000	$1.54	$21,560.00	25,000
8/27/2019	Daniel Barber	COO	Buy	2,000	$3.99	$7,980.00
8/21/2019	James S Scibetta	Director	Buy	22,971	$3.79	$87,060.09
8/13/2019	Keith J Kendall	CEO	Buy	1,300	$15.49	$20,137.00	993,524
8/12/2019	Peter E Boyd	SVP	Buy	600	$3.81	$2,286.00
8/9/2019	Theresa Wood	SVP	Buy	1,000	$3.99	$3,990.00
12/10/2018	Daniel Barber	SVP	Buy	1,000	$8.00	$8,000.00
12/6/2018	Alexander Mark Schobel	Insider	Buy	2,000	$8.69	$17,380.00
12/6/2018	John T Maxwell	CFO	Buy	5,000	$8.87	$44,350.00
11/27/2018	Keith J Kendall	CEO	Buy	1,000	$9.87	$9,870.00
11/26/2018	Theresa Wood	SVP	Buy	500	$10.34	$5,170.00
11/23/2018	Keith J Kendall	CEO	Buy	7,950	$10.10	$80,295.00
11/21/2018	Alexander Mark Schobel	Insider	Buy	1,000	$10.25	$10,250.00
11/21/2018	John T Maxwell	CFO	Buy	10,000	$9.80	$98,000.00
11/21/2018	Peter E Boyd	SVP	Buy	200	$9.98	$1,996.00

Insider Trading at Aquestive Therapeutics?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Aquestive Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Aquestive Therapeutics (NASDAQ:AQST)

45.45% of Aquestive Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aquestive Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/17/2021	Geneos Wealth Management Inc.	23,300	$94K	0.0%	N/A	0.064%
5/18/2021	Morgan Stanley	358,042	$1.86M	0.0%	+929.7%	0.978%
5/18/2021	Jane Street Group LLC	13,360	$69K	0.0%	-76.5%	0.037%
5/17/2021	Nuveen Asset Management LLC	764,217	$3.97M	0.0%	+43.9%	2.088%
5/17/2021	Goldman Sachs Group Inc.	46,826	$0.24M	0.0%	-8.5%	0.128%
5/14/2021	XTX Topco Ltd	10,970	$57K	0.0%	N/A	0.030%
5/13/2021	Trexquant Investment LP	10,227	$53K	0.0%	N/A	0.028%
5/13/2021	Barclays PLC	16,612	$86K	0.0%	+159.0%	0.045%
5/13/2021	Bank of New York Mellon Corp	164,259	$0.85M	0.0%	+82.5%	0.449%
5/13/2021	Massachusetts Financial Services Co. MA	54,495	$0.28M	0.0%	-10.6%	0.149%
5/12/2021	Northern Trust Corp	212,402	$1.10M	0.0%	-5.9%	0.580%
5/12/2021	Geode Capital Management LLC	354,856	$1.85M	0.0%	+13.3%	0.970%
5/12/2021	UBS Group AG	14,174	$74K	0.0%	-40.4%	0.039%
5/11/2021	Oak Grove Capital LLC	15,500	$81K	0.0%	-73.9%	0.042%
5/10/2021	HighTower Advisors LLC	68,617	$0.36M	0.0%	N/A	0.188%
5/10/2021	GSA Capital Partners LLP	207,609	$1.08M	0.2%	N/A	0.567%
5/7/2021	BlackRock Inc.	1,356,400	$7.05M	0.0%	+3.9%	3.707%
5/7/2021	IndexIQ Advisors LLC	89,390	$0.47M	0.0%	N/A	0.259%
4/26/2021	Wedbush Securities Inc.	10,000	$52K	0.0%	N/A	0.029%
2/24/2021	Virtu Financial LLC	59,050	$0.32M	0.0%	-49.6%	0.176%
2/23/2021	CWA Asset Management Group LLC	11,284	$60K	0.0%	N/A	0.034%
2/19/2021	JPMorgan Chase & Co.	38,863	$0.21M	0.0%	+187.5%	0.116%
2/17/2021	Oak Grove Capital LLC	59,500	$0.32M	0.1%	-33.1%	0.177%
2/17/2021	Jane Street Group LLC	56,752	$0.30M	0.0%	-10.1%	0.169%
2/16/2021	Squarepoint Ops LLC	42,797	$0.23M	0.0%	N/A	0.127%
2/16/2021	Nuveen Asset Management LLC	531,086	$2.84M	0.0%	+329.1%	1.580%
2/16/2021	Engineers Gate Manager LP	49,000	$0.26M	0.0%	-28.3%	0.146%
2/12/2021	Financial Advocates Investment Management	14,200	$76K	0.0%	N/A	0.042%
2/11/2021	Northern Trust Corp	225,604	$1.21M	0.0%	-2.7%	0.671%
2/11/2021	Barclays PLC	6,415	$34K	0.0%	-29.4%	0.019%
2/11/2021	Citigroup Inc.	10,138	$54K	0.0%	+418.6%	0.030%
2/10/2021	Rhumbline Advisers	19,740	$0.11M	0.0%	+17.6%	0.059%
2/10/2021	Renaissance Technologies LLC	271,800	$1.45M	0.0%	N/A	0.808%
2/9/2021	Wells Fargo & Company MN	61,641	$0.33M	0.0%	-3.6%	0.183%
2/9/2021	CWA Asset Management Group LLC	11,284	$60K	0.0%	N/A	0.034%
2/9/2021	Bank of New York Mellon Corp	90,019	$0.48M	0.0%	+76.8%	0.268%
2/5/2021	BlackRock Inc.	1,305,838	$6.99M	0.0%	+2.8%	3.884%
1/28/2021	Dupont Capital Management Corp	44,289	$0.24M	0.0%	+38.0%	0.132%
1/25/2021	Nisa Investment Advisors LLC	65,000	$0.35M	0.0%	N/A	0.193%
12/11/2020	Virtu Financial LLC	117,206	$0.57M	0.1%	+972.0%	0.349%
11/17/2020	Jane Street Group LLC	63,138	$0.31M	0.0%	+470.1%	0.188%
11/16/2020	Cubist Systematic Strategies LLC	39,400	$0.19M	0.0%	N/A	0.117%
11/16/2020	AQR Capital Management LLC	19,010	$92K	0.0%	N/A	0.057%
11/16/2020	ExodusPoint Capital Management LP	26,808	$0.13M	0.0%	N/A	0.080%
11/13/2020	Morgan Stanley	642,883	$3.12M	0.0%	+1,035.0%	1.912%
11/13/2020	Oak Grove Capital LLC	89,000	$0.43M	0.2%	+26.4%	0.265%
11/13/2020	Charles Schwab Investment Management Inc.	181,110	$0.88M	0.0%	+236.0%	0.539%
11/12/2020	JPMorgan Chase & Co.	13,516	$60K	0.0%	+49.0%	0.040%
11/12/2020	Massachusetts Financial Services Co. MA	61,566	$0.30M	0.0%	N/A	0.183%
11/9/2020	The Manufacturers Life Insurance Company	12,873	$62K	0.0%	N/A	0.038%
11/6/2020	BlackRock Inc.	1,270,074	$6.17M	0.0%	-10.9%	3.778%
11/5/2020	New York State Common Retirement Fund	10,000	$49K	0.0%	-46.8%	0.030%
11/5/2020	California Public Employees Retirement System	41,300	$0.20M	0.0%	+112.9%	0.123%
11/5/2020	Wells Fargo & Company MN	63,912	$0.31M	0.0%	+41.6%	0.190%
11/2/2020	Telemus Capital LLC	10,000	$50K	0.0%	N/A	0.030%
10/29/2020	Dupont Capital Management Corp	32,093	$0.16M	0.0%	N/A	0.095%
10/20/2020	Wedbush Securities Inc.	103,240	$0.50M	0.0%	-24.6%	0.307%
9/15/2020	Two Sigma Advisers LP	23,800	$0.12M	0.0%	+37.6%	0.071%
8/25/2020	Nuveen Asset Management LLC	106,355	$0.52M	0.0%	N/A	0.316%
8/20/2020	Charles Schwab Investment Management Inc.	53,908	$0.26M	0.0%	N/A	0.160%
8/17/2020	Engineers Gate Manager LP	25,900	$0.13M	0.0%	N/A	0.077%
8/17/2020	Jacobs Levy Equity Management Inc.	10,000	$49K	0.0%	-82.9%	0.030%
8/17/2020	Jane Street Group LLC	11,075	$54K	0.0%	N/A	0.033%
8/17/2020	Perceptive Advisors LLC	1,750,000	$8.51M	0.1%	N/A	5.205%
8/14/2020	Bank of America Corp DE	50,550	$0.25M	0.0%	+95.1%	0.150%
8/12/2020	Bank of Montreal Can	6,818	$31K	0.0%	-31.9%	0.020%
8/12/2020	American International Group Inc.	12,153	$59K	0.0%	N/A	0.036%
8/12/2020	Goldman Sachs Group Inc.	19,851	$96K	0.0%	N/A	0.059%
8/12/2020	Bank of New York Mellon Corp	59,268	$0.29M	0.0%	N/A	0.176%
8/7/2020	State Board of Administration of Florida Retirement System	12,689	$62K	0.0%	N/A	0.038%
8/7/2020	Virtu Financial LLC	10,933	$53K	0.0%	N/A	0.033%
8/7/2020	New York State Common Retirement Fund	18,800	$91K	0.0%	N/A	0.056%
7/31/2020	UBS Group AG	38,081	$0.19M	0.0%	+98.5%	0.113%
7/30/2020	Hancock Whitney Corp	23,293	$0.11M	0.0%	N/A	0.069%
7/16/2020	Wedbush Securities Inc.	136,923	$0.67M	0.1%	+57.8%	0.408%
6/16/2020	Royal Bank of Canada	13,569	$29K	0.0%	-66.9%	0.040%
5/15/2020	Squarepoint Ops LLC	16,425	$36K	0.0%	-11.9%	0.049%
5/15/2020	Tower Research Capital LLC TRC	21,622	$47K	0.0%	+60.8%	0.064%
5/15/2020	Two Sigma Advisers LP	17,300	$38K	0.0%	+57.3%	0.052%
5/13/2020	Canada Pension Plan Investment Board	175,000	$0.38M	0.0%	N/A	0.521%
5/12/2020	Spark Investment Management LLC	15,300	$33K	0.0%	-67.7%	0.046%
5/12/2020	JPMorgan Chase & Co.	413,962	$0.91M	0.0%	+29.9%	1.233%
5/11/2020	Oak Grove Capital LLC	70,400	$0.15M	0.1%	+369.3%	0.210%
5/11/2020	DG Capital Management LLC	546,249	$1.20M	1.9%	N/A	1.627%
5/5/2020	Creative Planning	18,000	$39K	0.0%	N/A	0.054%
5/1/2020	BlackRock Inc.	211,462	$0.46M	0.0%	+3.5%	0.630%
5/1/2020	UBS Group AG	19,188	$42K	0.0%	+91.9%	0.057%
4/17/2020	Wedbush Securities Inc.	86,766	$0.19M	0.0%	+39.0%	0.258%
2/20/2020	Geode Capital Management LLC	88,068	$0.51M	0.0%	+176.6%	0.352%
2/14/2020	Perceptive Advisors LLC	2,250,000	$13.10M	0.3%	N/A	8.985%
2/14/2020	Wildcat Capital Management LLC	455,358	$2.65M	0.8%	N/A	1.818%
2/14/2020	Cubist Systematic Strategies LLC	17,926	$0.10M	0.0%	N/A	0.072%
2/14/2020	Bank of America Corp DE	26,243	$0.15M	0.0%	N/A	0.105%
2/14/2020	Jacobs Levy Equity Management Inc.	25,066	$0.15M	0.0%	-78.1%	0.100%
2/14/2020	Goldman Sachs Group Inc.	48,336	$0.28M	0.0%	+373.5%	0.193%
2/13/2020	Laurion Capital Management LP	104,301	$0.61M	0.0%	N/A	0.416%
2/13/2020	Banco Bilbao Vizcaya Argentaria S.A.	30,000	$0.17M	0.0%	N/A	0.120%
2/13/2020	Oxford Asset Management LLP	311,539	$1.81M	0.1%	+330.9%	1.244%
2/13/2020	Renaissance Technologies LLC	79,000	$0.46M	0.0%	N/A	0.315%
2/12/2020	Trexquant Investment LP	22,344	$0.13M	0.0%	N/A	0.089%

Data available starting January 2016

Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.

Today's Range

Now: $3.24

$3.12

$3.44

50 Day Range

MA: $3.78

$3.32

$4.44

52 Week Range

Now: $3.24

$3.17

$9.47

Volume

23,241 shs

Average Volume

754,492 shs

Market Capitalization

$118.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.59

Who are the company insiders with the largest holdings of Aquestive Therapeutics?

Aquestive Therapeutics' top insider shareholders include:

Alexander Mark Schobel (Insider)
Keith J Kendall (CEO)
John T Maxwell (CFO)
Lori J Braender (SVP)
Daniel Barber (COO)
James S Scibetta (Director)
Peter E Boyd (SVP)
Theresa Wood (SVP)

The Dark Side Of The Electric Vehicle Boom

From The Gold Letter | Ad

There's not enough of this valuable resource to meet demand. But this company might change that...

Get The Inside Scoop Now